Bioantibody

佰抗生物

Bioantibody

Enterprise Software/SaaS

Baikang Biotech develops core upstream raw materials for in vitro diagnostics and biopharmaceuticals. The company is a nationally certified high-tech enterprise focused on IVD raw materials, IVD reagents, and early-stage discovery of therapeutic antibody drugs.

Latest round: Series A (2023)

Source: ChinaBulls — chinabulls.com

Last updated 2023-01-01

Funding history

Request access to view this section.

Investors

Request access to view this section.

HQ & website

Request access to view this section.

Tags

Request access to view this section.